Europe - Germany • Industry focus
Baker McKenzie
We only have limited information for this firm. Consider the following firms which have provided more information:
Baker McKenzie‘s advice comprehensively covers all healthcare and life sciences matters. The team is particularly well versed in regulatory and pharmaceutical law, here, practice head Thilo Räpple is a key contact; typical instructions pertain to regulatory compliance as well as physician, hospital, pharmacy and food law or pharmaceutical advertising law and social security matters. The pharmaceutical and healthcare technology industries are also increasingly advised on in the context of telemedical projects, while licensing matters are another growth area. Räpple is supported by Martin Altschwager (European and German pharmaceutical and medical device law, compliance, competition law issues in connection with healthcare products and services).
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'An incredibly high level of expertise and yet a focus on the essentials! It doesn't get any better.'
'The team is very consistent on a global level in terms of quality.'
Abbreviated data is displayed for this firm.
Key clients
- Hexal AG
Abbreviated data is displayed for this firm.
Work highlights
- Advising international pharmaceutical companies and leading pharmaceutical industry associations on security of supply in pharmaceutical discount agreements and the privileging of EU production sites.
- Advising and representing international and German pharmaceutical companies in defending against contractual penalty and damages claims from statutory health insurance companies due to delivery failures when implementing drug discount contracts with disputed amounts totaling several million euros.
Abbreviated data is displayed for this firm.